Initial Results of D3 Lymphadenectomy in the Surgical Treatment of Cancer of the Right Half of the Segmented Intestine
https://doi.org/10.24060/2076-3093-2018-8-2-58-62
Abstract
Introduction. Despite recent significant progress in chemotherapy treatment of primary non-metastatic cancer of the right half of the segmented intestine, surgery remains the primary method of treatment. Radical surgery includes removal of the tumour within the healthy tissues and regional lymph glands. Considering localisation of the primary tumour in the right half of the segmented intestine, hemicolectomy is typically performed on the right side. W. Hohenberger et al. have formulated a new concept of radical surgical treatment of the segmented intestine, consisting of the following components: complete mesocolic excision, early ligation of the lymphovascular pedicle and lymph dissection in the D3 volume.
Purpose of the research: to analyse the early results of surgical treatment of cancer in the right half of the segmented intestine in the volume of the right-side hemicolectomy with D3 lymph node dissection depending on the method of surgical treatment.
Materials and methods. At the premises of the Surgical Department No. 3 of the Republican Oncologic Dispensary (city of Ufa) a retrospective analysis of data of 59 patients was performed following right-side hemicolectomy using complete mesocolic excision, ligation lymphovascular pedicles and lymph node dissection in the D3 volume. Depending on the surgical access, all patients were divided into two main groups: group I (48 patients) — surgeries were performed using open method; group II (11 patients) — using laparoscopy.
Results and discussion. Table 2 shows that the surgery performed with laparoscopy takes longer. However, statistically it results in significantly less blood loss. Patients who underwent open surgery were characterised by a longer stay in hospital. One of the effectiveness criteria is the number of removed lymph glands not differing for either group.
Conclusion. Extended lymph dissection in the D3 volume for segmented intestine on the right side during cancer is a possible and safe method in case of laparoscopic and open procedures.
About the Authors
R. T. AiypovRussian Federation
Candidate of Medical Sciences, Deputy Head,
73/1 Oktyabrya avenue, Ufa, 450054
R. I. Safiullin
Russian Federation
Doctor of Medical Sciences, Professor at the Department of Urology with the Additional Professional Education course,
3 Lenin str., Ufa, 450006
M. R. Garipov
Russian Federation
Oncologist,
73/1 Oktyabrya avenue, Ufa, 450054
D. V. Feoktistov
Russian Federation
Head of the Department of Surgery,
73/1 Oktyabrya avenue, Ufa, 450054
N. A. Tarasov
Russian Federation
Oncologist,
73/1 Oktyabrya avenue, Ufa, 450054
A. A. Garipova
Russian Federation
Attending Physician of the Department of Paediatric Surgery,
3 Lenin str., Ufa, 450006
R. R. Garipov
Russian Federation
Post-graduate student of the Department of Oncology with the course of Additional Professional Education,
3 Lenin str., Ufa, 450006
References
1. Wong J.C., Lau J.Y., Suen B.Y., Ng S.C., Wong M.C., Tang R.S., Wong S.H. Prevalence, distribution, and risk factor for colonic neoplasia in 1133 subjects aged 40–49 undergoing screening colonoscopy. J Gastroenterol Hepatol. 2017;32(1):92–7. DOI: 10.1111/jgh.13450
2. Basheev V.Kh., Mutyk M.G., Balaban V.V. Preliminary results of treatment of right colon cancer with complete mesocolic excision and D3 lymph node dissection. Neoplasms. 2017;9(2):97–105. (in Russ.)
3. Aleksandrova L.M., Starinsky V.V., Kalinina A.M., Kaprin A.D., Boytsov S.A. Results of malignancy detection during prophylactic medical examinations in 2013–2014. Terapevticheskiy arkhiv = Therapeutic archive. 2016;88(1):60–6. DOI: 10.17116/terarkh201688160-66 (in Russ.)
4. Kashchenko V.A., Petrov V.P., Vasyukova E.L. Issues of standardization of colon cancer surgery. Koloproktologiya. 2014;(2):4–10. (in Russ.)
5. Schmidt A., Beyna T., Schumacher B., Meining A., Richter-Schrag H.J., Messmann H., et al. Colonoscopic full-thickness resection using an over-the-scope device: a prospective multicentre study in various indications. Gut. 2018;67(7):1280–9. DOI: 10.1136/gutjnl-2016-313677
6. Kalinichenko A.Yu., Khalilov Z.B., Azimov R.Kh., Panteleeva I.S., Kurbanov F.S. Laparoscopic surgery for colon cancer. Khirurgiya. 2017;(7):14–7. DOI: 10.17116/hirurgia2017714-17 (in Russ.)
7. Fitzmaurice C., Allen C., Barber R.M., Barregard L., Bhutta Z.A., Brenner H., et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted lifeyears for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. DOI: 10.1001/jamaoncol.2016.5688
8. Efetov S.K., Tulina I.A., Kravchenko A.Yu., Fedorov D.N., Efetov S.V., Tsarkov P.V. Long-term results of treatment of right-sided colon cancer with mesocolic excision and D3-lymph node dissection. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014;24(1):62– 70. (in Russ.)
9. Chand M., Siddiqui M.R., Gupta A., Rasheed S., Tekkis P., Parvaiz A., et al. Systematic review of emergent laparoscopic colorectal surgery for benign and malignant disease. World J Gastroenterol. 2014;20(45):16956–63. DOI: 10.3748/wjg.v20.i45.16956
10. Twaij A., Pucher P.H., Sodergren M.H., Gall T., Darzi A., Jiao L.R. Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and metaanalysis. World J Gastroenterol. 2014;20(25):8274–81. DOI: 10.3748/wjg.v20.i25.8274
11. Liao G., Zhao Z., Lin S., Li R., Yuan Y., Du S., et al. Robotic-assisted versus laparoscopic colorectal surgery: a meta-analysis of four randomized controlled trials. World J Surg Oncol. 2014;12:122. DOI: 10.1186/1477-7819-12-122
12. West N.P., Kobayashi H., Takahashi K., Perrakis A., Weber K., Hohenberger W., et al. Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol. 2012;30(15):1763– 9. DOI: 10.1200/JCO.2011.38.3992
13. Munkedal D.L., Laurberg S., Hagemann-Madsen R., Stribolt K.J., Krag S.R., Quirke P., et al. Significant individual variation between pathologists in the evaluation of colon cancer specimens after complete mesocolic excision. Dis Colon Rectum. 2016;59(10):953–61. DOI: 10.1097/DCR.0000000000000671
14. Killeen S., Mannion M., Devaney A., Winter D.C. Complete mesocolic resection and extended lymphadenectomy for colon cancer: a systematic review. Colorectal Dis. 2014;16(8):577–94. DOI: 10.1111/codi.12616
15. Reha J., Mukkamalla S.K.R., Rathore R., Somasundar P.S. Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I–III colon cancer: A validation study using the National Cancer Data Base. Eur J Surg Oncol. 2018;44(1):148–56. DOI: 10.1016/j.ejso.2017.11.005
16. Del Paggio J.C., Nanji S., Wei X., MacDonald P.H., Booth C.M. Lymph node evaluation for colon cancer in routine clinical practice: a population-based study. Curr Oncol. 2017;24(1):e35–e43. DOI: 10.3747/co.24.3210
17. Emmanuel A., Haji A. Complete mesocolic excision and extended (D3) lymphadenectomy for colonic cancer: is it worth that extra effort? A review of the literature. Int J Colorectal Dis. 2016;31(4):797–804. DOI: 10.1007/s00384-016-2502-0
Review
For citations:
Aiypov R.T., Safiullin R.I., Garipov M.R., Feoktistov D.V., Tarasov N.A., Garipova A.A., Garipov R.R. Initial Results of D3 Lymphadenectomy in the Surgical Treatment of Cancer of the Right Half of the Segmented Intestine. Creative surgery and oncology. 2018;8(2):142-146. (In Russ.) https://doi.org/10.24060/2076-3093-2018-8-2-58-62